Indonesia COVID-19

Vaccine hesitancy in the predominantly Muslim country can be traced to apprehensions that shots other than the Chinese-made Sinovac are not "halal."

Quarantine, confusion, and red tape dash hopes of tourism reboot in Bali.

After announcing that year-end travel would be permitted, the government cancelled the Christmas Eve holiday, a Friday this year, in an effort to discourage vacationing somewhat. 

In 2022, the state intends to continue its robust spending on the areas most impacted by the COVID-19 pandemic: health and social assistance.

The approval of the Zifivax jab is set to add further momentum to the country's vaccine rollout, but serious obstacles remain

But Southeast Asia's largest country is not quite out of the woods yet.

The Indonesian government needs to jettison its hopes of a miracle cure to COVID-19, and listen to the advice of epidemiologists and health experts.

In recent weeks, the region has seen more than twice as many deaths from the coronavirus than North America.

President Joko Widodo said that the development of infrastructure and "quality human capital" will remain priorities for the remainder of his second term.

Just as cases are beginning to ease in densely populated Java and Bali, they are rising elsewhere.

The pandemic has highlighted deep-rooted problems in health service. Medical workers voicing out their concerns have put governments on the defensive.

Will mounting evidence about the limited efficacy of Chinese-made vaccines spell the end for Beijing's vaccine diplomacy?